Plunkett Research Online: Codexis Inc

CODEXIS INC (CDXS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Codexis, Inc. is a developer of proprietary biocatalysts, which are enzymes or microbes that initiate or accelerate chemical reactions. The company is currently selling its biocatalysts to customers in the pharmaceutical industry and is engaged in a multi-year research and development collaboration .....



Codexis Inc
Ticker: CDXS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 421-8100
Fax:
Address: 200 Penobscot Drive
Redwood, CA 94063 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biocatalyst Research & Development
Contacts Description

John Nicols CEO/Director/President
Gordon Sangster CFO/Chief Accounting Officer/Senior VP
See More
Codexis, Inc. is a developer of proprietary biocatalysts, which are enzymes or microbes that initiate or accelerate chemical reactions. The company is currently selling its biocatalysts to customers in the pharmaceutical industry and is engaged in a multi-year research and development collaboration .....See More See More

Auditor: BDO USA, LLP
Legal Advisor: Latham & Watkins LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: